Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIM60P3Y is a human pseudogene located on the Y chromosome, and its sequence is homologous to the TRIM (tripartite motif-containing) gene family, which encode proteins involved in various cellular processes such as immune response and transcriptional regulation. As a pseudogene, TRIM60P3Y is noncoding and does not produce a functional protein product; these genes typically arise from gene duplication or retrotransposition and accumulate mutations over time that render them inactive[2][7]. There is currently no evidence that TRIM60P3Y exerts a regulatory function, nor does it serve as a therapeutic target or biomarker in any human disease[2][3]. It should be considered a gene annotation artifact or genomic fossil with no therapeutic importance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 60 pseudogene 3, Y-linked (TRIM60P3Y).